AzTrials
AzTrials

Violence in AdolescenceETHRNCT05880979

Engaging Together for Healthy Relationships

A study testing Engaging Together for Healthy Relationships and Regular well child care in people with Violence in Adolescence and Domestic Violence, run by University of Pittsburgh at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this pilot randomized clinical trial is to assess feasibility and acceptability of a brief parent-adolescent dating violence prevention intervention (Engaging Together for Healthy Relationships; ETHR) delivered in pediatric primary care settings. Read more about this study

Who is it for?
Ages 11 years and olderHealthy volunteers can take part
Conditions the study is for
Violence in Adolescence, Domestic Violence
What is being tested?
Engaging Together for Healthy Relationships and Regular well child care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
102 participants
Where
2 sitesUnited States
Study dates
1 Jul 2023to 1 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Providers:
  • Sees patient at an eligible primary care clinic
  • Speaks and understands English
  • Age 18 or older
  • Identifies as a pediatrician, nurse practitioner, physician assistant (pediatric primary care healthcare provider)
  • Adolescents
Show all 16Show fewer
  • Age 11 to 15
  • Attending an upcoming well-child visit from a provider enrolled in the study
  • Caregiver who is accompanying well-child visit with adolescent is also participating
  • Speaks and understands English
  • Parents
  • Is parent or primary caregiver for an adolescent age 11 to 15
  • Adolescent has an upcoming well-child visit with a provider enrolled in the study
  • Accompanying child to the well-visit
  • Adolescent is interested and eligible to participate in study
  • Speaks and understand English

Who cannot join

  • Providers
  • 1) Does not need inclusion criteria

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • CCP South Hills

    Monongahela, Pennsylvania, 15063

  • Primary Care Center Oakland

    Pittsburgh, Pennsylvania, 15213

Other trials in United States

About this study

Official title: Engaging Together for Healthy Relationships: A Pilot Trial to Test a Brief Dating Violence Prevention Intervention for Pediatric Primary Care

The goal of this pilot randomized clinical trial is to assess feasibility and acceptability of a brief parent-adolescent dating violence prevention intervention (Engaging Together for Healthy Relationships; ETHR) delivered in pediatric primary care settings. The main questions it aims to answer is if ETHR is acceptable and feasible. 4 healthcare providers will receive ETHR to share with their patients which includes clinician training, provider-delivered scripts, resource guides, and a comprehensive website. This will be compared to providers conducting routine well-child care with their patients.

Read the detailed description

The investigators are conducting a pilot randomized clinical trial to test a brief parent-adolescent dating violence prevention intervention (Engaging Together for Healthy Relationships; ETHR). ETHR has been developed for parents and adolescents, to be implemented within pediatric primary care settings. ETHR is a comprehensive intervention which includes a training for clinicians, brief educational scripts for providers, resource guides for the adolescent, parent, and dyad, a comprehensive website, and warm referral processes to connect families with local resources. The investigators will be comparing ETHR with routine care. The specific goal of the pilot trial is to test trial feasibility, as well as intervention acceptability and fidelity. The investigators also will be examining exploratory changes in secondary outcomes and early implementation barriers and facilitators.

Four pediatric clinics will participate in this study. The investigator will recruit two providers from each clinic and randomize them into the intervention provider or control provider. The intervention provider will receive ETHR and the control provider will complete their regular well-child care. The investigators will enroll 15 families in the intervention arm and 5 in the control arm (3:1 enrollment). Families who are seeing the intervention provider for a well-child visit will be enrolled in the intervention arm; those seeing the control provider will be enrolled in the control arm. Families will be eligible if they are seeing the intervention or control providers for a well child visit, if the adolescent coming for the well-visit is between 11 to 15, if both the caregiver and adolescent are interested in participating, and if the family speaks and understands English. Families will be called 2 weeks ahead of their visit to enroll, consent, and complete a baseline survey (both the adolescent and parent will complete the survey). Participants will then attend their well -visit (where they will receive ETHR or routine care, depending on their provider). They will complete an acceptability and fidelity survey immediately post-visit, a resource utilization survey 1 month post visit, and a follow up survey (identical to the baseline survey) 3 months post visit. Providers will complete a brief fidelity and acceptability survey after each study visit (15 for intervention providers, 5 for control providers). All providers and a subset of families enrolled in the intervention arm (20 dyads, 40 participants) will also complete post-intervention interviews.

Being tested
Engaging Together for Healthy Relationships, Regular well child care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Engaging Together for Healthy RelationshipsBehavioural

    A comprehensive parent-adolescent dating violence prevention intervention designed to be provider delivered within the context of a pediatric well-child visit

  • Regular well child careBehavioural

    Participants will receive their regularly scheduled well-child care

Study groups in NCT05880979
Study groupRoleWhat they receive
Intervention (Engaging Together for Healthy Relationships)ExperimentalProviders and families in the intervention arm will receive the ETHR program which includes a clinician training, provider scripts, resource guides, a comprehensive website, and warm referral processes.
Receives: Behavioral: Engaging Together for Healthy Relationships
Control (Receipt of regular well-child care)Active comparatorProviders and families in the control arm will receive regular well-child care. All providers in the control arm will have access to ETHR after the pilot trial is over
Receives: Behavioral: Regular well child care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of participants who are eligible out of the total who are approached

    Will assess through tracking data

    Measured: Through completion of study recruitment, an average of 6 months

  2. Percentage of participants who are consented out of the total who are eligible

    Will assess through tracking data

    Measured: Through completion of study recruitment, an average of 6 months

  3. Percentage of participants who complete the baseline survey out of the total who consented

    Will assess through tracking data

    Measured: Through completion of completing baseline surveys, an average of 6 months

  4. Percentage of participants who complete the well-visit out of the total who consented

    Will assess through tracking data

    Measured: Through completion of completing well-visits, an average of 6 months

  5. Percentage of participants who complete the immediate post-intervention survey out of the total who consented

    Will assess through tracking data

    Measured: Through completion of completing post-intervention survey, an average of 7 months

  6. Percentage of participants who complete the 1-month post-intervention survey out of the total who consented

    Through completion of completing 1- month post-intervention survey, an average of 8 months

    Measured: 4 months

  7. Percentage of participants who complete the 3-month post-intervention survey out of the total who consented

    Will assess through tracking data

    Measured: Through completion of completing 3 month post-intervention survey, an average of 12 months

  8. Percentage of participants who strongly agree or agree that the intervention is acceptable using a 4-item validated measure (Acceptability of Intervention Measure)

    Validated measure (Acceptability of Intervention Measure)

    Measured: Through completion of completing immediate post-visit surveys, an average of 6 months

Secondary outcomes (6)
  1. Self-efficacy in preventing adolescent relationship abuse (ARA), change in outcome between baseline and 3 months

    Self-efficacy around ARA prevention, 1-5 scale (5=higher self-efficacy)

    Measured: Baseline, 3-month post intervention

  2. Percentage of participants who utilize ARA resources at each measurement point, change in outcome over time

    Investigator developed measure (yes/no)

    Measured: Baseline, 1 month post intervention, 3 month post-intervention

  3. Attitudes about ARA, change in outcome between baseline and 3 months

    Attitudes about Abusive Relationships, 1-5 scale (1=not abusive, 5=very abusive)

    Measured: Baseline, 3-month post intervention

  4. Parent-adolescent communication around dating and ARA, change in outcome over time

    Investigator developed measure, yes/no answer choices (yes=has communicated, no=has not communicated)

    Measured: Baseline, 3-month post intervention

  5. Parental monitoring around dating and ARA, change in outcome over time

    Parenting Practices Scale (never to always; 1=never, 5=always)

    Measured: Baseline, 3-month post intervention

  6. Percentage of adolescents reporting ARA victimization and perpetration

    CADRI Short Form 1-5 scale (never to everyday)

    Measured: Baseline, 3-month post intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 May 2023
  2. Study start1 Jul 2023
  3. Primary completion1 Nov 2024
  4. Study completion1 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomization will occur at the provider-level
Masking
Single blind
Who is masked
Participant
Enrolment
102 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05880979
Sponsor's protocol ID
STUDY22060047
Acronym
ETHR
Status last verified
Feb 2025
First submitted
12 May 2023
Last updated
3 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Engaging Together for Healthy Relationships and Regular well child care in people with Violence in Adolescence and Domestic Violence, run by University of Pittsburgh at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of participants who are eligible out of the total who are approached (time frame: Through completion of study recruitment, an average of 6 months). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2025; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in